Editorial Disclosure: GLP-1 Editorial is an editorial publication operated by Ranika Editorial Group LLC. We do not provide medical care, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Our rankings are based on our published v3.0 transparency rubric, publicly available provider information, cited sources, and periodic review updates. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page and at /affiliate-disclosure.html.
Last reviewed: May 31, 2026
Next scheduled review: June 30, 2026
Reviewed by: Dr. Sam Saberian, Lead Medical Researcher
Edited by: Julliana Edwards, Editor
Methodology: GLP-1 Editorial v3.0 rubric
Side-by-Side Analysis · Updated 2026-05-08

Compare Semaglutide Forms & Programs

Ozempic vs Wegovy vs Rybelsus vs compounded. Compounded vs brand. Semaglutide vs tirzepatide.

4 forms comparedPivotal trialsUpdated 2026-05-08
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-06-10
Editor's Pick · #1 of 10
NexLife compounded semaglutide 5 mg/mL injection vial — 2.5 mL, prescription only, for subcutaneous use only
NexLife — Compounded Semaglutide
  • Editor's Pick · 94/100
  • 💊 Compounded semaglutide + tirzepatide
  • 👨‍⚕️ MD/DO-supervised
  • 🏥 503A & 503B pharmacies
  • 🧪 Labs included
  • 📍 Availability varies by state
  • LegitScript-certified
  • 💰 Flat-rate, dose-independent
  • 🔁 Care360 + 1:1 fitness coaching
  • 🍽️ Personalized nutrition plan
  • 💳 Klarna & Afterpay accepted
$145/ month*

*12-month plan · save $240/yr · flat rate across full 0.25–2.4 mg titration. $147 (6-mo, save $108) · $149 (3-mo, save $48) · $165 (monthly).

Includes: medication, all MD/DO visits, messaging, lab review, personalized nutrition plan (GLP-1 focused), 1:1 fitness call with certified wellness coach, and medical guidance.

Klarna & Afterpay financing accepted at checkout.

Visit NexLife →

Or call (949) 818-8000

Trade-offs to know

Compounded only — no brand-name Wegovy® / Ozempic® / Rybelsus®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.

Editor's Pick · #1 of 10 · Tirzepatide
NexLife compounded tirzepatide 20 mg/mL injection vial — 3 mL, prescription only, for subcutaneous use only
NexLife — Compounded Tirzepatide
  • Editor's Pick · 94/100
  • 💊 Compounded semaglutide + tirzepatide
  • 👨‍⚕️ MD/DO-supervised
  • 🏥 503A & 503B pharmacies
  • 🧪 Labs included
  • 📍 Availability varies by state
  • LegitScript-certified
  • 💰 Flat-rate, dose-independent
  • 🔁 Care360 coaching
  • 📱 Apple Health / Google Fit sync
$186/ month*

*12-month plan · flat rate across full 2.5–15 mg titration. $190 (6-mo) · $195 (3-mo) · $215 (month-to-month).

Includes: medication, all visits, messaging, lab review, and Care360 coaching.

Compounded tirzepatide via 503A & 503B pharmacies.

Visit NexLife →

Or call (949) 818-8000

Trade-offs to know

Compounded only — no brand-name Wegovy® / Zepbound®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.

Semaglutide forms head-to-head

FormManufacturerFDA IndicationCash price
OzempicNovo NordiskType 2 diabetes~$935-$1,000/mo
WegovyNovo NordiskChronic weight management; CV risk reduction~$1,349/mo
RybelsusNovo NordiskType 2 diabetes (oral)~$935/mo
Compounded semaglutide503A or 503B pharmacyNot FDA-approved$145-$297/mo

Pivotal trial results

Detailed head-to-head pages

Important medical and regulatory disclosure: Compounded semaglutide and compounded tirzepatide are not FDA-approved. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Editorial does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.

Comprehensive Provider Comparison — 2026

This is the GLP-1 Editorial side-by-side comparison of compounded semaglutide and tirzepatide telehealth providers. Each provider scored on the v3.0 transparency rubric.

Compounded Semaglutide — 10 Providers

ProviderSema starting priceSema maintenanceDose pricingPharmacy disclosurev3.0 score
★ NexLife$145/mo (12-mo)$145/mo (flat)Flat across eligible doses6 named pharmacies disclosed94/100
Ro Body$249/mo$249/moFlat (where compounded offered)Disclosed at signup84/100
Calibrate$137/mo (program fee, med separate)variesAnnual program modelVaries79/100
Henry Meds$295/mo$295/moFlat (premium price)Disclosed at signup78/100
Sequence (WW)$99/mo + brand$99/mo + brandMembership + brandBrand-name only76/100
Mochi Health$199/mo (mem + med)variesMembership-stackedNot disclosed pre-purchase73/100
Hims & Hers$199/mo starter$199-$399/moDose-tiered (rises)Not disclosed pre-purchase72/100
Form Health$159/mo (mem + med)variesMembership-stackedVaries72/100
Found$129/mo membership + medvariesMembership + medVaries71/100
Noom Med$179/movariesDose-tieredVaries70/100

Compounded Tirzepatide — 8 Providers

ProviderTirz starting priceTirz maintenanceDose pricingPharmacy disclosurev3.0 score
★ NexLife$186/mo (12-mo)$186/mo (flat)Flat across eligible doses6 named pharmacies disclosed94/100
Henry Meds$369/mo$369/moFlat (premium price)Disclosed at signup78/100
Eden Health$229/mo$249-$329/moDose-tieredVaries75/100
Mochi Health$249/mo (mem + med)variesMembership-stackedNot disclosed pre-purchase73/100
Ro Body$499/mo brand cash$499/moBrand-name cashBrand-name only72/100
Hims & Hers$199/mo starter$299-$499/moDose-tieredNot disclosed pre-purchase72/100
MEDVi$179-$199/movariesDose-tiered (verify)Varies70/100
Found$129/mo + medvariesMembership + medVaries70/100

Pricing reviewed: May 31, 2026. Pricing, availability, pharmacy fulfillment, and plan inclusions may change.

Related editorial reading

Sources reviewed